Skip to main content

Glomerulonephritis with organized immunoglobulin deposits: fibrillar and microtubular deposits are associated with distinct immunological features

  • Chapter
Monoclonal Gammopathies and the Kidney

Abstract

Non-amyloid glomerulopathies characterized by Congo-red negative organized immunoglobulin (Ig) deposits display two characteristic patterns by electron microscopy (EM); either randomly arranged (pseudo-amyloid) fiibrils or microtubules usually larger and ordered in parallel arrays 1–23. It is currently unclear whether this morphological distinction is relevant. Certain investigators consider that such a distinction is of no clinical or pathophysiological basis, and propose that fiibrillar and microtubular Ig deposits are merely variants of the same glomerulopathy, referred to as fiibrillary-immunotactoid GN3,1 5,1 g,2o They also advocate that this diagnosis should be limited to patients with primary renal disorders, thus excluding patients with monoclonal gammopathy, systemic diseases or lymphoproliferative disorders3,7. Others suggest that distinguishing immunotactoid (IT) GN and FGN is critical 10,12–14,19 In immunotactoid GN, defiined by the presence of orderly arranged microtubules usually more than 30 nm in width, glomerular Ig are often monotypic. Immunotactoid GN may be associated with monoclonal gammopathy and/or hematological malignancy with improved renal prognosis after chemotherapy6,10,13,14 On the contrary, in FGN the diameter of fiibrils is less than 30 nm and these patients present without underlying hematological disease5,8,12,13,22,23 Moreover, a predominance of polyclonal IgG4 in glomerular deposits has been reported in FGN 12,16,23, but not in immunotactoid GN3,6,14.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenmann E, Eliakim M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron. 1977;18:301–8.

    Article  PubMed  CAS  Google Scholar 

  2. Duffy JL, Khurana E, Susin M, Gomez-Leon G, Churg J. Fibrillary renal deposits and nephritis. Am J Pathol. 1983;113:279–90.

    PubMed  CAS  Google Scholar 

  3. Korbet SM, Schwartz MM, Rosenberg BF, Sibley RK, Lewis EJ. Immunotactoid glomerulopathy. Medicine. 1985;64:228–43.

    Article  PubMed  CAS  Google Scholar 

  4. Sturgill BC, Bolton WK, Griffiith KM. Congo-red negative amyloidosis-like glomerulopathy. Hum Pathol. 1985;16:200–24.

    Article  Google Scholar 

  5. Alpers CE, Rennke HJ, Hopper J, Biava CG. Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features. Kidney Int. 1987;31:781–9.

    Article  PubMed  CAS  Google Scholar 

  6. Touchard G, Preud’homme JL, Aucouturier P et al. Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study. Clin Nephrol. 1989; 31:107–16.

    PubMed  CAS  Google Scholar 

  7. Mazzucco G, Casanova S, Donini U et al. Glomerulonephritis with organized deposits: a new clinicopathological entity? Light-, electron-microscopic and immunofluorescence study of 12 cases. Am J Nephrol. 1990;10:21–30.

    Article  PubMed  CAS  Google Scholar 

  8. Esparza AR, Chazan JA, Nayak RN, Cavallo T. Fibrillary (immunotactoid) glomerulopathy. A possible role for kappa light chain in its etiology and/or pathogenesis. Am J Surg Pathol. 1991;15:632–43.

    Article  PubMed  CAS  Google Scholar 

  9. Casanova S, Donini U, Zucchelli P, Mazzucco G, Monga G, Linke RP. Immunohistochemical distinction between amyloidosis and fibrillar glomerulopathy. Am J Clin Pathol. 1992; 97:787–95.

    PubMed  CAS  Google Scholar 

  10. Alpers CE. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fiibrillary glomerulonephritis? Am J Kidney Dis. 1992;19:185–91.

    PubMed  CAS  Google Scholar 

  11. Yang GCH, Nieto R, Stachura I, Gallo GR. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo red-negative amyloid-like fiibrils of fibrillary glomerulopathy. Am J Pathol. 1992;141:409–19.

    PubMed  CAS  Google Scholar 

  12. Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fiibrillary glomerulonephritis. Kidney Int. 1992;42:1401–7.

    Article  PubMed  CAS  Google Scholar 

  13. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993;22:367–77.

    PubMed  CAS  Google Scholar 

  14. Touchard G, Bauwens M, Goujon JM, Aucouturier P, Patte D, Preud’homme JL. Glomerulonephritis with organized microtubular monoclonal immunoglobulin deposits. Adv Nephrol Necker Hosp. 1994;23:149–75.

    PubMed  CAS  Google Scholar 

  15. Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG. Clinical features, predictors of disease progression and results of renal transplantation in fiibrillary/immunotactoid glomerulopathy. Nephrol Dial Transplant. 1996;11:837–42.

    Article  PubMed  CAS  Google Scholar 

  16. Coroneos E, Truong L, Olivero J. Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis. 1997;29:132–5.

    Article  PubMed  CAS  Google Scholar 

  17. Markowitz GS, Cheng JT, Colvin RT, Trebbin WM, D’Agati V. Hepatitis C viral infection is associated with fiibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998;9:2244–52.

    PubMed  CAS  Google Scholar 

  18. Korbet SM, Schwartz MM, Lewis EJ. Immunotactoid glomerulopathy. Am J Kidney Dis. 1991;17:247–57.

    PubMed  CAS  Google Scholar 

  19. Jennette JC, Iskandar SS, Falk RJ. Fibrillary glomerulonephritis. In Tisher CG, Brenner BM, editors. Renal Pathology: With Clinical and Functional Correlations, 2nd edn. Philadelphia: JB Lippincott, 1994:553–63.

    Google Scholar 

  20. Brady HR. Fibrillary glomerulopathy. Kidney Int. 1998;53:1421–9.

    Article  PubMed  CAS  Google Scholar 

  21. van Ginneken EEM, Assmann KJM, Koolen MI, Jansen JLJ, Wetzels JF. Fibrillary-immunotactoid glomerulopathy with renal deposits of IgAλ: a rare cause of glomerulonephritis. Clin Nephrol. 1999;52:383–9.

    PubMed  Google Scholar 

  22. King JAC, Culpepper RM, Corey GR, Tucker JA, Lajoie G, Howell DN. Glomerulopathies with fiibrillary deposits. Ultrastruct Pathol. 2000;24:15–21.

    Article  PubMed  CAS  Google Scholar 

  23. Haas MH, Nair R, Kovesdy C. Renal biopsy teaching case. A 49-year-old woman with hematuria, proteinuria, and glomerular immune complex deposits containing IgA and IgG. Am J Kidney Dis. 2000;36:1281–85.

    Article  PubMed  CAS  Google Scholar 

  24. Cheson BD, Bennett JM, Grever M et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–7.

    PubMed  CAS  Google Scholar 

  25. Harris NL, Jaffe ES, Stein H et al. A revised European-American classifiication of lymphoid neoplasms: a proposal from the International Lymphoma Study group. Blood. 1994;84:1361–92.

    PubMed  CAS  Google Scholar 

  26. Kyle RA. ‘Benign’ monoclonal gammapathy – after 20 to 35 years of follow-up. Mayo Clin Proc. 1993;68:26–36.

    Article  PubMed  CAS  Google Scholar 

  27. Binet JL, Leporrier M, Dighiero G et al. A clinical staging system for chronic lymphocytic leukemia. Prognostic signifiicance. Cancer. 1977;40:855–64.

    Article  PubMed  CAS  Google Scholar 

  28. Beaume A, Brizard A, Dreyfus B, Preud’homme JL. High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood. 1994; 84:1216–19.

    PubMed  CAS  Google Scholar 

  29. Moulin B, Ronco PM, Mougenot B, François A, Fillastre JP, Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 1992;42:127–35.

    Article  PubMed  CAS  Google Scholar 

  30. Morel-Maroger L, Verroust P. Glomerular lesions in dysproteinemias. Kidney Int. 1974; 5:249–52.

    Article  PubMed  CAS  Google Scholar 

  31. Preud’Homme JL, Seligmann M. Anti-human IgG activity of membrane bound monoclonal immunoglobulin M in lymphoproliferative disorders. Proc Natl Acad Sci USA. 1972;69:2132–5.

    Article  PubMed  Google Scholar 

  32. Spiegelberg HL. Biological role of different antibody classes. Int Arch Allergy Appl Immunol. 1989;90(Suppl. 1):22–7.

    Article  PubMed  CAS  Google Scholar 

  33. Preud’homme JL, Aucouturier P, Touchard G et al. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int. 1994;46:965–72.

    Article  PubMed  Google Scholar 

  34. Ronco PM, Aucouturier P, Mougenot B. Monoclonal gammopathies: multiple myeloma, amyloidosis, and related disorders. In Schrier RW, Gottschalk CW, editors. Diseases of the Kidney. Boston: Little Brown, 1996;2129–74.

    Google Scholar 

  35. Preud’homme JL, Seligmann M. Surface-bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood. 1972;40:777–94.

    PubMed  Google Scholar 

  36. Guglielmi P, Preud’homme JL, Gourdin MF, Reyes F, Daniel MT. Unusual intracytoplasmic immunoglobulin inclusions in chronic lymphocytic leukemia. Br J Haematol. 1982;50:123–34.

    Article  PubMed  CAS  Google Scholar 

  37. Saluk PH, Clem W. Studies on the cryoprecipitation of a human IgG3 cryoglobulin: the effects of temperature-induced conformational changes on the primary interaction. Immunochemistry. 1975;12:29–37.

    Article  CAS  Google Scholar 

  38. Vialtel P, Kells DI, Pinteric L, Dorrington KJ, Klein M. Nucleation-controlled polymerization of human monoclonal immunoglobulin G cryoglobulins. J Biol Chem. 1982;257:3811–18.

    PubMed  CAS  Google Scholar 

  39. Rocca A, Khamlichi A, Touchard G et al. Sequences of VKI subgroup light chains in Fanconi’s syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi’s syndrome. J Immunol. 1995;155:3245–52.

    PubMed  CAS  Google Scholar 

  40. Steiner LA, Dwight Lopes A. The crystallizable human myeloma protein DOB has a hingeregion deletion. Biochemistry. 1979;18:4054–67.

    Article  PubMed  CAS  Google Scholar 

  41. Khamlichi AA, Rocca A, Touchard G, Aucouturier P, Preud’homme JL, Cogné M. Role of light chain variable region in myeloma with light chain deposition disease: evidence from an experimental model. Blood. 1995;86:3655–9.

    PubMed  CAS  Google Scholar 

  42. Decourt C, Rocca A, Bridoux F et al. Mutational analysis in murine models for myelomaassociated Fanconi’s syndrome or cast nephropathy. Blood. 1999;94:3559–66.

    PubMed  CAS  Google Scholar 

  43. Rengers JU, Touchard G, Decourt C, Deret S, Michel H, Cogné M. Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia. Blood. 2000;95:3467–72.

    PubMed  CAS  Google Scholar 

  44. Dussol B, Kaplanski G, Daniel L, Brunet P, Pellissier JF, Berland Y. Simultaneous occurrence of fiibrillary glomerulopathy and AL amyloid. Nephrol Dial Transplant. 1998;13:2630–2.

    Article  PubMed  CAS  Google Scholar 

  45. Gallo G, Picken M, Buxbaum J, Frangione B. The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin Hematol. 1989;26:234–45.

    PubMed  CAS  Google Scholar 

  46. Preud’homme JL, Buxbaum J, Scharff MD. Mutagenesis of mouse myeloma cells with ‘Melphalan’. Nature. 1973;245:320–2.

    Article  Google Scholar 

  47. Rostagno A, Vidal R, Kumar A et al. Fibrillary glomerulonephritis related to serum fiibrillar immunoglobulin-fiibronectin complexes. Am J Kidney Dis. 1996;28:676–84.

    Article  PubMed  CAS  Google Scholar 

  48. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical signifiicance of cryoglobulins. Am J Med. 1974;57:775–88.

    Article  PubMed  CAS  Google Scholar 

  49. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355–77.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bridoux, F. et al. (2003). Glomerulonephritis with organized immunoglobulin deposits: fibrillar and microtubular deposits are associated with distinct immunological features. In: Touchard, G., Aucouturier, P., Hermine, O., Ronco, P. (eds) Monoclonal Gammopathies and the Kidney. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0191-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0191-4_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-6199-7

  • Online ISBN: 978-94-017-0191-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics